Morgan Stanley Vaccitech PLC Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Vaccitech PLC stock. As of the latest transaction made, Morgan Stanley holds 11,983 shares of VACC stock, worth $40,862. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,983

Previous 8,873 35.05%

Holding current value

$40,862

Previous $30,000 33.33%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	N/A	3,110 Added 35.05%	11,983 $40,000
Q2 2024 Oct 17, 2024	SELL	N/A	-3,989 Reduced 31.01%	8,873 $30,000
Q2 2024 Aug 14, 2024	SELL	N/A	-3,989 Reduced 31.01%	8,873 $30,000
Q1 2024 Oct 17, 2024	BUY	$3.41 - $3.7 $13,602 - $14,759	3,989 Added 44.96%	12,862 $43,000
Q1 2024 Aug 16, 2024	SELL	$3.41 - $3.7 $12,293 - $13,338	-3,605 Reduced 21.89%	12,862 $43,000
Q1 2024 May 15, 2024	SELL	$3.41 - $3.7 $12,293 - $13,338	-3,605 Reduced 21.89%	12,862 $43,000
Q4 2023 Aug 16, 2024	BUY	$2.72 - $5.0 $20,655 - $37,970	7,594 Added 85.59%	16,467 $60,000
Q4 2023 Feb 13, 2024	SELL	$2.72 - $5.0 $12,914 - $23,740	-4,748 Reduced 22.38%	16,467 $60,000
Q3 2023 Nov 15, 2023	BUY	$1.68 - $3.16 $9,690 - $18,226	5,768 Added 37.34%	21,215 $65,000
Q2 2023 Aug 14, 2023	SELL	$2.06 - $2.51 $109,901 - $133,908	-53,350 Reduced 77.55%	15,447 $31,000
Q1 2023 May 15, 2023	BUY	$2.16 - $3.15 $123,081 - $179,493	56,982 Added 482.29%	68,797 $154,000
Q4 2022 Feb 14, 2023	SELL	$2.1 - $2.68 $1,581 - $2,018	-753 Reduced 5.99%	11,815 $27,000
Q3 2022 Nov 14, 2022	SELL	$3.06 - $6.19 $3,797 - $7,681	-1,241 Reduced 8.99%	12,568 $40,000
Q2 2022 Oct 27, 2022	BUY	$3.09 - $6.21 $13,938 - $28,013	4,511 Added 48.52%	13,809 $61,000
Q2 2022 Aug 15, 2022	BUY	$3.09 - $6.21 $13,938 - $28,013	4,511 Added 48.52%	13,809 $61,000
Q1 2022 Oct 27, 2022	SELL	$4.51 - $11.75 $20,344 - $53,004	-4,511 Reduced 32.67%	9,298 $48,000
Q1 2022 May 13, 2022	SELL	$4.51 - $11.75 $1,501 - $3,912	-333 Reduced 3.46%	9,298 $48,000
Q4 2021 Feb 14, 2022	SELL	$8.98 - $15.55 $129,698 - $224,588	-14,443 Reduced 59.99%	9,631 $107,000
Q3 2021 Nov 15, 2021	BUY	$14.0 - $16.5 $337,036 - $397,221	24,074 New	24,074 $379,000

Others Institutions Holding VACC

# of Institutions

Shares Held

14.9M

Call Options Held

Put Options Held

View Full List

About Vaccitech plc

Ticker VACC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,216,200
Market Cap $127M
Description
Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. The company's therapeutic programs include VTP-300, which is in Phase 1/2a clinical trial for the treatment of chronic hepatitis B...

More about VACC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account